JAK Inhibitors in Pediatric Patients | Practical Pearls from the Expert
Be excited about the new medications approved for use in pediatric patients, says Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Kirkorian about the use of JAK inhibitors in children. Should dermatology clinicians prescribe JAK inhibitors in this patient …
Be excited about the new medications approved for use in pediatric patients, says Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Kirkorian about the use of JAK inhibitors in children. Should dermatology clinicians prescribe JAK inhibitors in this patient … Continue reading "JAK Inhibitors in Pediatric Patients | Practical Pearls from the Expert"
A 44-year-old man with a history of diabetes, hypertension, and major depressive disorder presents to the office with the eruption shown for several months. The lesions are also all across the patient's back and have not resolved with twice-daily clobetasol 0.05% ointment application for 2 months. Which of the following is the most appropriate treatment?
A. Intralesional triamcinolone
B. Nar … 